SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-030211
Filing Date
2017-05-05
Accepted
2017-05-05 12:25:08
Documents
2
Period of Report
2017-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8579
2 POA DOCUMENT poa.txt EX-24.3_721549 3124
  Complete submission text file 0001209191-17-030211.txt   13276
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD., SUITE 130 NEWARK CA 94560
Business Address
Menold Daniel (Reporting) CIK: 0001705745 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 17817163